Pulmonary nodule
Conditions
Interventions
Observation group:A mixture of liposome bupivacaine and bupivacaine hydrochloride for thoracic paravertebral nerve block
Control group:Ropivacaine hydrochloride for thoracic paravertebral nerve block
Sponsors
The First Affiliated Hospital of Xinxiang Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients between the ages of 18 and 80. Planned patients undergoing thoracoscopic lung wedge resection. Have appropriate cognitive and language skills to communicate effectively and understand pain assessment and post-operative follow-up procedures.
Exclusion criteria
Exclusion criteria: Pregnant or lactating women. Patients with severe cardiovascular disease, liver insufficiency, renal insufficiency, or other vital organ system diseases. Patients with a known allergy to local anesthetics or related drugs. Patients with known central nervous system disorders such as epilepsy or Parkinson's disease. Patients with bleeding predisposition or who are receiving anticoagulant therapy. Patients with mental illness, cognitive impairment, or other conditions that affect self-assessment of pain. Patients who have received interventional treatment related to pain perception (e.g. nerve block, physical therapy, etc.). Patients who have been treated with medications related to pain relief (such as analgesics, antidepressants, etc.). Patients unable to follow study protocols, including those unable to participate in follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain;Opioid use; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complication;Time of first opiate use after surgery; | — |
Countries
China
Contacts
Public ContactHongwei Zhang
The First Affiliated Hospital of Xinxiang Medical College
Outcome results
None listed